Inactivation of cAMP receptor protein (MSMEG_6189) increases isoniazid susceptibility in Mycobacterium smegmatis via altered oxidative phosphorylation, elevated ROS production, and loss of ahpC expression
ABSTRACT Isoniazid (INH) is a first-line drug for treating drug-susceptible tuberculosis. The genome of Mycobacterium smegmatis encodes two cAMP receptor proteins (Crp), MSMEG_6189 (Crp1) and MSMEG_0539 (Crp2). The deletion of crp1 markedly increased susceptibility to INH, whereas the deletion of cr...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology
2025-12-01
|
| Col·lecció: | Journal of Bacteriology |
| Matèries: | |
| Accés en línia: | https://journals.asm.org/doi/10.1128/jb.00429-25 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|